Article

Using IPL to treat glaucoma patients with dry eye disease

 

Steven Vold, MD, founder and CEO of Vold Vision in Northwest Arkansas, shares how his practice uses intense pulsed light (IPL) therapy to treat dry eye disease (DED) in glaucoma patients, during the 2019 American Academy of Ophthalmology annual meeting in San Francisco.

See more content from AAO 2019. 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.